These studies support our findings that low levels of Ccl17 and Cxcl13, Cxcr3, and Sema3a as well as high levels of Nr4a1 in SB2−/−;PyMT tumors may delay mammary tumor development and may lead to decreased metastasis. This evidence concerns the gene CXCL13 and breast cancer.